Stay updated on EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial
Sign up to get notified when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.

Latest updates to the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check50 days agoChange Detected- Revision: v3.4.2 added and Revision: v3.4.1 removed. This is a site maintenance update and does not modify study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check58 days agoChange DetectedAdministrative notices about government funding and site status were added, along with revision metadata (Revision: v3.4.1 and dates like 2026-02-02 and 2027-02-26). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check65 days agoChange DetectedShow glossary has been added, and timestamp/metadata labels have been updated to include 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', along with a new 'Revision: v3.4.0' line. The older labels such as 'Last Update Submitted that met QC Criteria', 'Last Update Posted (Estimated)', and 'No FEAR Act data' appear to be adjusted or removed, reflecting UI/metadata changes rather than core content.SummaryDifference0.2%

- Check79 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3. This is a metadata update and does not modify the study details or outcomes.SummaryDifference0.0%

Stay in the know with updates to EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.